Cameroon-Based Non-Profit HEADA Acquires Metabiota

The Cameroonian non-profit organization Health and Development in Action (HEADA) today announced its acquisition of Metabiota, Inc., a leading US-based organization dedicated to global health and to mitigating the risk of pandemics. HEADA will immediately take over projects in HIV prevention, avian and human influenza surveillance, and pandemic preparedness in Cameroon, Democratic Republic of Congo, and Sierra Leone. Funders of this work include the US Department of Defense, the US Centers for Disease Control and Prevention and USAID. Metabiota’s core capacities include developing and strengthening disease surveillance systems, building, and maintaining national infectious disease laboratory systems, and strengthening the public health workforce. The transfer of Metabiota to HEADA aligns with the US government’s vision of “localization,” strengthening local capacities and ownership in low- and middle-income countries out of a recognition that local actors are best positioned to drive their country’s development. For more information, see the HEADA website and press release here.

Ginkgo Bioworks Acquires Metabiota's Data & Analytics Technology and Team

Ginkgo Bioworks has announced the acquisition of Metabiota's proprietary datasets, modeling and analytic tools, and its software platform with the capabilities to track, model, and forecast epidemics and associated risks and impacts. In addition to epidemiological tracking and forecasting, Metabiota created specialized data infrastructure to help governments and other partners understand and model the risks and disruptive impacts of pathogens in order to promote resilience to pandemics and epidemics. Ginkgo also expects to integrate several ongoing epidemiological analysis projects and a team of epidemiological data experts into its biosecurity and public health initiative, Concentric by Ginkgo. Following the acquisition of the data & analytics business unit, Metabiota's remaining business will continue its vital work in government services dedicated to public health program interventions. View the full press release here.

Metabiota Partners with FII Institute and Accenture to Launch the Global Infectious Diseases Index

FII Institute launched a unique global index that uses groundbreaking technology to track infectious diseases and transform how the world reacts to future crises. The Global Infectious Diseases Index was developed by FII Institute in partnership with Accenture and Metabiota. Metabiota's risk solution program was among the first to flag unusual infections in Wuhan in December 2019. For more information, visit the Global Infectious Disease Index and the associated press release. 

How might probability inform policy on pandemics? Metabiota has ideas

There is a 47% to 57% chance the world will experience another pandemic or epidemic that kills at least as many people as COVID-19 in the next 25 years, according to estimates from Metabiota, a San Francisco-based company that tracks infectious disease risks and outbreaks. Metabiota applies catastrophe risk modeling — which allows financial institutions, insurers, and public agencies to understand the likelihood of extreme events and crises, such as wildfires, floods, and earthquakes — to pandemics and epidemics. For more information on Metabiota's application of catastrophe risk modeling, view the full article on Devex. 

Metabiota Awarded as Technology Pioneer by World Economic Forum

The World Economic Forum announced its selection of the 100 most promising Technology Pioneers of 2021 – companies that are shaping industries from healthcare to retail and many more. This year’s cohort includes representation from 26 economies on six continents with reach far beyond traditional tech hubs like Silicon Valley. Metabiota, the global pioneer in infectious disease risk solutions, made it to the selection for its contributions in the field of infectious disease analytics and risk management The full list of Technology Pioneers can be viewed here and press release can be viewed here. 

New Case Study on Metabiota's Epidemic Detection System

Metabiota has released a new case study after Metabiota’s early insights into the COVID-19 pandemic provided critical data to make operational decisions. According to Eran Ben-Shushan, CEO of the events software company Bizzabo, “Metabiota provided crucial early warning about the potential effects of the COVID pandemic in January 2020, prompting Bizzabo to make an early pivot from in-person to online events. This led to 100%+ growth in revenue for the year, rather than the extreme losses that many in the in-person events industry have faced.” Read the full story in this case study.

Metabiota in Modern Insurance Magazine: Industry Innovators Interview

Metabiota’s mission is to make the world more resilient to epidemics. Following the impact of Covid-19, change is on the horizon as the need to cover risk becomes ever more prevalent. Nita Madhav, CEO of Metabiota, discusses Metabiota’s work and ability to mitigate against the outbreaks. Epidemic risk factors will only continue to escalate across the globe, and Metabiota is working hard to inform the industry of the data and tools available that could help them mitigate against future epidemic and pandemic risks and their consequences.  View full article in Modern Insurance Magazine.

Metabiota in the Cameroon Tribune: MINDEF: Minister Encourages Army Health Research Centre

The Minister Delegate at the Presidency in charge of Defence, Joseph Beti Assomo paid a working visit to the Army Health Research Centre (CRESAR) and Metabiota teams on October 15, 2020, a culmination of 20 years of successful collaborative efforts.   CRESAR began in 2000 with a mission to carry out research and laboratory testing for the Defence Forces, their families, and other populations in Cameroon. Together with Metabiota, CRESAR has contributed enormously to public health in the military and general Cameroonian population.  View full article in Cameroon Tribune. 

Metabiota in Homeland Preparedness News: Bipartisan Commission on Biodefense prepares for next pandemic

The ongoing COVID-19 pandemic is revealing major gaps in national readiness to prepare for, respond to, and recover from biological threats, requiring that decision makers consider improved policies, programs, and technologies to ramp up the federal defense, experts said during the Sept. 24 virtual meeting of the Bipartisan Commission on Biodefense. View article for more information on the Bipartisan Commission on Biodefense and Metabiota.

Metabiota in S&P Global Market Intelligence: Human behavior biggest challenge in race to model pandemic risk

Capturing how individuals and governments respond to pandemics is one of the key challenges to developing risk models that could underpin future insurance solutions, according to specialists. View article in S&P Global Market Intelligence:  Human behavior biggest challenge in race to model pandemic risk